Torii Pharmaceutical Co Ltd 4551
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- JPY 3,975.00
- Day Range
- JPY 3,960.00–4,035.00
- 52-Week Range
- JPY 3,275.00–4,370.00
- Bid/Ask
- JPY 3,960.00 / JPY 3,975.00
- Market Cap
- JPY 111.58 Bil
- Volume/Avg
- 20,600 / 32,372
Key Statistics
- Price/Earnings (Normalized)
- 21.93
- Price/Sales
- 1.99
- Dividend Yield (Trailing)
- 3.02%
- Dividend Yield (Forward)
- 3.02%
- Total Yield
- 3.02%
Company Profile
Torii Pharmaceutical Co Ltd is a major drug manufacturing company. The company utilizes strategic partnerships with other pharmaceutical companies in order to combine research and marketing functions. Torii's key therapeutic areas include renal diseases, hemodialysis, HIV, skin diseases, and allergens. The vast majority of the company's net mainstay product sales are derived from the renal diseases and hemodialysis operations, followed by HIV. Torii's places its strategic focus on prompt market penetration and expansion of new products as well as maximizing values of mainstay products in each priority area.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 626
- Website
- http://www.torii.co.jp
Comparables
Valuation
|
Metric
|
4551
|
INVA
|
1SKF401E
|
|---|---|---|---|
Price/Earnings (Normalized) | 21.93 | 9.28 | — |
Price/Book Value | 0.94 | 1.43 | — |
Price/Sales | 1.99 | 4.26 | — |
Price/Cash Flow | 30.16 | 7.98 | — |
Price/Earnings
4551
INVA
1SKF401E
Financial Strength
|
Metric
|
4551
|
INVA
|
1SKF401E
|
|---|---|---|---|
Quick Ratio | 5.80 | 7.28 | 5.90 |
Current Ratio | 7.05 | 9.03 | 5.90 |
Interest Coverage | — | 10.31 | — |
Quick Ratio
4551
INVA
1SKF401E
Profitability
|
Metric
|
4551
|
INVA
|
1SKF401E
|
|---|---|---|---|
Return on Assets (Normalized) | 5.21% | 14.79% | 11.93% |
Return on Equity (Normalized) | 5.79% | 29.29% | 14.50% |
Return on Invested Capital (Normalized) | 5.54% | 16.71% | 14.48% |
Return on Assets
4551
INVA
1SKF401E
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Fvzydnld | Wbjk | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Rvxqcktvsw | Bykxndr | $69.1 Bil | |
HLN
| Haleon PLC ADR | Sncfhtqn | Qgsl | $37.8 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Stkzmgqz | Zmww | $15.7 Bil | |
VTRS
| Viatris Inc | Nwmghrk | Fgpqf | $13.8 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Bctxqxqg | Kpps | $12.4 Bil | |
CTLT
| Catalent Inc | Hpgyqqmsg | Hkvpnp | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Tvwzhksj | Fzxw | $4.5 Bil | |
CURLF
| Curaleaf Holdings Inc | Tdfxdsqt | Nlzq | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Cnyrgnxz | Dxhxkzg | $3.5 Bil |